Robert L Van Nostrand Sellas Life Sciences Group, Inc. (SLS) insider trading activity

Robert L Van Nostrand is Director of SELLAS Life Sciences Group, Inc.. Currently has a direct ownership of 82,900 shares of SLS, which is worth approximately $118,547. The most recent transaction as insider was on Jan 07, 2026, when has been sold 50,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 82.9K

306.37% 3M change

262.01% 12M change

Total Value Held $118,547

ROBERT L VAN NOSTRAND Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 07 2026	BUY Grant, award, or other acquisition	-	50,000 Added 37.62%	82,900 Common Stock
Jun 12 2025	BUY Open market or private purchase	$14,800 $1.48 p/Share	10,000 Added 32.89%	20,400 Common Stock
Jan 10 2025	BUY Grant, award, or other acquisition	-	12,500 Added 35.31%	22,900 Common Stock
Jan 22 2024	BUY Grant, award, or other acquisition	-	6,000 Added 36.59%	10,400 Common Stock
Feb 02 2023	BUY Grant, award, or other acquisition	-	2,500 Added 36.23%	4,400 Common Stock
Jan 31 2022	BUY Grant, award, or other acquisition	-	1,900 Added 50.0%	1,900 Common Stock

Also insider at

ITCI

Intra-Cellular Therapies, Inc. Healthcare

YTEN

YIELD10 BIOSCIENCE, INC. Basic Materials

Director

RLV